Home › Funds › Parkman Healthcare Partners LLC › CLYM

Parkman Healthcare Partners LLC position in CLYM

CLIMB BIO INC · Health Care

Parkman Healthcare Partners LLC reported holding 563,484 shares of CLYM (CLIMB BIO INC) in its Q2 2026 13F filing — a position valued at US$7.3M, representing 0.75% of its reported portfolio and ranking #47 among its reported holdings. Parkman Healthcare Partners LLC has disclosed CLYM holdings in 3 of the last 8 reported quarters, going back to Q3 2024.

Latest position (Q2 2026)563.48K sh
Reported value held$7.35M
Portfolio Weight0.75%
First reportedQ3 2024
Last changeNew
Updated2026-10-24

Last updated: 2026-10-24 · Source: SEC EDGAR Form 13F-HR

How Parkman Healthcare Partners LLC's CLYM position evolved

Parkman Healthcare Partners LLC first disclosed a stake in CLYM in Q3 2024 at 278,775 shares (US$1.4M). The position peaked in Q2 2026 at 563,484 shares, worth US$7.3M. Across 3 filings, Parkman Healthcare Partners LLC increased the stake 1 time(s), trimmed it 0 time(s) and left it unchanged 0 time(s). The most recent filing (Q2 2026) shows 563,484 shares valued at US$7.3M.

Quarter by quarter

QuarterSharesValueChange
Q3 2024 278.77K $1.42M New
Q4 2024 290.49K $522.88K Add
Q2 2026 563.48K $7.35M New

Dots on the line are colored by change type; missing quarters mean no position was reported.

About CLYM and 13F data

CLYM (CLIMB BIO INC) is a Health Care company. 75 other funds we track also report a position in CLYM — the largest reported positions include RA CAPITAL MANAGEMENT, L.P. (US$147.4M), BRAIDWELL LP (US$36.5M), Cormorant Asset Management, LP (US$27.5M). Under SEC rules, institutional investment managers with over $100M in assets must file Form 13F within 45 days of each quarter-end, disclosing long positions in US-listed equities. The data excludes short positions, most options and foreign holdings, so treat it as a quarterly snapshot rather than a live position.

Other funds holding CLYM

All CLYM fund holders →

FAQ

How long has Parkman Healthcare Partners LLC held CLYM?

Parkman Healthcare Partners LLC has disclosed CLYM holdings in 3 of the last 8 reported quarters, going back to Q3 2024.

What is Parkman Healthcare Partners LLC's current position in CLYM?

As of Q2 2026, Parkman Healthcare Partners LLC holds 563.48K shares of CLYM (CLIMB BIO INC), valued at $7.35M, representing 0.75% of its reported portfolio and ranking #47.

Has Parkman Healthcare Partners LLC been buying or selling CLYM?

In the latest 13F filing (Q2 2026), Parkman Healthcare Partners LLC newly opened its position in CLYM. The position peaked in Q2 2026 at 563.48K shares.

Which other funds hold CLYM?

Other major institutional holders of CLYM include RA CAPITAL MANAGEMENT, L.P., BRAIDWELL LP, Cormorant Asset Management, LP, among 75 funds with disclosed positions.

Where does this data come from?

All figures are computed from SEC Form 13F quarterly filings, which institutional investment managers must file within 45 days of quarter end for long positions of $100,000 or more.